Earnings Volatility Drives These Healthcare Stocks in a New Direction

Antares Pharma Inc (NASDAQ:ATRS) had a loss and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.03 in the quarter versus EPS of $0.00 in the year-earlier quarter. Revenue Decreased 34.4% to $4.5 million from the year-earlier quarter.

reported adjusted EPS loss of $0.03 per share. By that measure, the company missed the mean analyst estimate of $-0.03. It missed the average revenue estimate of $5.12 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

ATRS

ArQule Inc. (NASDAQ:ARQL) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.09 in the quarter versus EPS of $-0.08 in the year-earlier quarter. Revenue Decreased 33.41% to $5.66 million from the year-earlier quarter.

ArQule Inc. reported adjusted EPS loss of $0.09 per share. By that measure, the company beat the mean analyst estimate of $-0.11. It beat the average revenue estimate of $3.78 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

ARQL

VIVUS Inc. (NASDAQ:VVUS) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.53 in the quarter versus EPS of $-0.20 in the year-earlier quarter. Revenue Was the same at $4.11 million as the year-earlier quarter.

VIVUS Inc. reported adjusted EPS loss of $0.53 per share. By that measure, the company missed the mean analyst estimate of $-0.51. It missed the average revenue estimate of $5.22 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

VVUS

POZEN, Inc. (NASDAQ:POZN) had a loss and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.19 in the quarter versus EPS of $-0.28 in the year-earlier quarter. Revenue Rose 10.08% to $1.42 million from the year-earlier quarter.

POZEN, Inc. reported adjusted EPS loss of $0.19 per share. By that measure, the company missed the mean analyst estimate of $-0.19. It missed the average revenue estimate of $1.43 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

POZN

Accuray Incorporated (NASDAQ:ARAY) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.37 in the quarter versus EPS of $-0.13 in the year-earlier quarter. Revenue Decreased 30.71% to $70.55 million from the year-earlier quarter.

Accuray Incorporated reported adjusted EPS loss of $0.37 per share. By that measure, the company missed the mean analyst estimate of $-0.22. It missed the average revenue estimate of $77.97 million.

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

ARAY

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:   , , , ,  

More from The Cheat Sheet